WHO Launches First Global System to Track Abortion Care Quality, Rights and Outcomes

The WHO’s new Measuring Abortion Care Framework and Indicators (MACFI) introduces the first global system for monitoring abortion care through 93 standardized indicators, helping countries measure service quality, access, legal environments and health outcomes. The framework provides governments, development partners and private-sector stakeholders with a roadmap to strengthen reproductive healthcare, improve policy decisions, reduce maternal health risks and advance gender equality.

The World Health Organization (WHO) has introduced the Measuring Abortion Care Framework and Indicators (MACFI), the first global framework designed to standardize how abortion care is measured, monitored and improved across countries. Developed with contributions from more than 90 experts representing leading universities, research institutions, health organizations and civil society groups worldwide, the framework aims to address a major gap in reproductive health governance: the lack of consistent and comparable data on abortion care.

The report highlights that despite growing attention to reproductive health, abortion measurement remains highly fragmented. Earlier reviews found more than 1,000 different abortion-related indicators being used by governments, NGOs and research institutions, making comparisons across countries difficult. To solve this problem, WHO has created a menu of 93 validated indicators covering health systems, clinical care, legal and policy environments, and community empowerment. The framework is intended to help governments, development partners and healthcare providers monitor progress and identify gaps in abortion care services.

A New Tool for Better Health Governance

At the core of MACFI is a five-stage measurement model that tracks progress from policy and governance structures to health and social impacts. The framework evaluates whether countries have supportive laws, adequate financing, trained healthcare workers, reliable medicine supplies, effective service-delivery systems and strong health information systems.

The report places particular emphasis on the availability of essential abortion medicines such as misoprostol and mifepristone, inclusion of abortion services in national health benefit packages, and adoption of evidence-based clinical protocols. It also examines whether countries are using innovative service-delivery models such as telemedicine and digital health platforms.

For policymakers, the framework provides a practical roadmap for identifying weaknesses in health systems and ensuring that reproductive health services align with international standards. By introducing common indicators, WHO hopes to improve accountability and support evidence-based policymaking at national and subnational levels.

Economic Benefits and Development Impact

The report makes a strong case that quality abortion care is not only a health issue but also an economic and development priority. Poor access to safe abortion services often leads to complications that require emergency treatment, hospitalization and additional healthcare spending. These costs place pressure on already stretched health systems and can create significant financial burdens for households.

By improving service quality, affordability and accessibility, countries can reduce preventable complications and improve health outcomes. Better reproductive healthcare also contributes to workforce participation, educational attainment and women's economic empowerment. The framework directly links quality abortion care to progress on Sustainable Development Goal (SDG) 3 on health and well-being and SDG 5 on gender equality.

The report further argues that investments in reproductive health systems generate broader development benefits by reducing maternal mortality and morbidity while supporting individuals' ability to make informed reproductive choices. These outcomes have long-term implications for poverty reduction, social inclusion and human capital development.

Opportunities and Challenges for Development Partners and Business

For international development agencies, donors and multilateral organizations, MACFI offers a common measurement platform that can improve programme monitoring and evaluation. Standardized indicators can strengthen results-based financing models, improve reporting consistency and enable more meaningful comparisons across countries and projects.

The framework also identifies priority areas for future investment, including health information systems, workforce training, supply-chain management, community outreach and stigma reduction. These are areas where donor support can help countries strengthen health systems while generating measurable results.

Private-sector stakeholders may also find new opportunities emerging from the framework. Pharmaceutical companies, digital health providers, telemedicine platforms, healthcare technology firms and data analytics companies are likely to play an increasing role as countries modernize reproductive healthcare services. The report recognizes telemedicine, digital support tools and self-managed care models as important components of future service delivery.

However, the framework also highlights risks. Digital platforms must address concerns around privacy, misinformation, unequal internet access and regulatory compliance. Companies involved in reproductive healthcare will face growing expectations to provide evidence-based information, protect user data and ensure equitable access to services.

Closing Data Gaps and Building Future-Ready Systems

While MACFI represents a major step forward, WHO acknowledges that important measurement gaps remain. Several areas still lack validated indicators, including abortion financing, self-managed abortion, digital health interventions, provider education, stigma reduction and implementation of abortion-related laws and policies.

The report recommends that governments integrate abortion indicators into national health information systems, establish baseline measurements and regularly track progress. Development partners are encouraged to invest in research and data systems that can strengthen evidence generation and support future indicator development.

Ultimately, the framework provides more than a monitoring tool. It offers a strategic blueprint for building stronger health systems, improving accountability and advancing reproductive rights. By introducing 93 standardized indicators within a comprehensive results framework, WHO aims to help countries make informed policy decisions, improve healthcare quality and accelerate progress toward global health and development goals.